A Double-Blind, Double-Dummy, Randomized, Crossover Study to Compare the Tolerability of Quetiapine Fumarate Immediate Release (SEROQUEL) [quetiapine] With Quetiapine Fumarate Extended Release (SEROQUEL XR) [quetiapine] During Initial Dose Escalation in Healthy Volunteers
Phase of Trial: Phase I
Latest Information Update: 17 Jul 2009
At a glance
- Drugs Quetiapine (Primary)
- Indications Bipolar disorders; Schizophrenia
- Focus Adverse reactions; Pharmacokinetics
- Sponsors AstraZeneca
- 17 Jul 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 24 Jul 2008 Status changed from recruiting to in progress according to ClinicalTrials.gov.
- 16 Jul 2008 New trial record.